FDA Approves Abbott’s Libre Rio and Lingo Over-the-Counter CGMs

Man wearing a continuous glucose monitor (CGM) sensor on the back of his arm, with a smartphone screen displaying real-time glucose data in a colorful graph.

The over-the-counter CGM market has two new players…the Lingo and Libre Rio. The two systems created by Abbott were intentionally designed to meet different needs – Lingo for those who want to better understand and improve their health and wellness, and Libre Rio for adults with type 2 diabetes who do not use insulin and typically manage their diabetes through lifestyle modifications.

read more

Glucagon Updates You NEED to Know, Including Mini-Dosing!

For years and years (and years), the “red suitcase” was the main glucagon rescue kit most people with type 1 diabetes had stashed somewhere in case of emergency. Thankfully, we now have two newer glucagon options that are much easier to administer. Drs. E+P explain how to use each one, and they discuss the research and off-label mini-dose glucagon experiments people are conducting that may be a mirror into the future.

read more

Dexcom Stelo: The First Over-the-Counter CGM for Type 2 Diabetes Gets FDA Approval

Dexcom Stelo Glucose Biosensor

Up until now, it’s been difficult for people newly diagnosed with type 2 diabetes, or those not on inulin, to get CGM covered by insurance. Thanks to the FDA’s recent approval of Dexcom Stelo – a CGM that can be purchased over-the-counter without a prescription – people with type 2 diabetes who are not on insulin will now be able to benefit from invaluable CGM technology.

read more